Ronald J. Tallarida
#110,699
Most Influential Person Now
Researcher
Ronald J. Tallarida's AcademicInfluence.com Rankings
Ronald J. Tallaridachemistry Degrees
Chemistry
#2143
World Rank
#3005
Historical Rank
Chemical Engineering
#182
World Rank
#196
Historical Rank
Physical Chemistry
#230
World Rank
#269
Historical Rank
Download Badge
Chemistry
Ronald J. Tallarida's Degrees
- PhD Chemistry University of California, Berkeley
- Masters Chemical Engineering Stanford University
Why Is Ronald J. Tallarida Influential?
(Suggest an Edit or Addition)Ronald J. Tallarida's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Manual of Pharmacologic Calculations: With Computer Programs (1984) (1109)
- Drug synergism: its detection and applications. (2001) (700)
- Drug Synergism and Dose-Effect Data Analysis (2000) (565)
- An Overview of Drug Combination Analysis with Isobolograms (2006) (477)
- pA2 and receptor differentiation: a statistical analysis of competitive antagonism. (1979) (398)
- Statistical analysis of drug-drug and site-site interactions with isobolograms. (1989) (385)
- Manual of Pharmacologic Calculations (1981) (385)
- Table of Integrals (1999) (356)
- Quantitative methods for assessing drug synergism. (2011) (258)
- The interaction index: a measure of drug synergism (2002) (251)
- The Dose—Response Relation in Pharmacology (1979) (248)
- Statistical analysis of drug combinations for synergism (1992) (233)
- Efficient designs for studying synergistic drug combinations. (1997) (153)
- Interactions between drugs and occupied receptors. (2007) (135)
- Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats 1 An abstract of this study was presented at the 1997 APS Meeting (New Orleans). 1 (1999) (128)
- Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia (2011) (120)
- Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction. (1990) (119)
- Revisiting the Isobole and Related Quantitative Methods for Assessing Drug Synergism (2012) (114)
- Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles (2004) (113)
- Metabolic changes associated with the cessation of cigarette smoking. (1970) (112)
- Chi-Square Test (1987) (111)
- Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram. (1995) (110)
- Single and combined effects of Δ9‐tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy‐induced neuropathic pain (2017) (108)
- Subclasses of opioids based on body temperature change in rats: acute subcutaneous administration. (1983) (99)
- Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum (1999) (98)
- Discovery of "self-synergistic" spinal/supraspinal antinociception produced by acetaminophen (paracetamol). (2000) (93)
- Response surface analysis of synergism between morphine and clonidine. (1999) (89)
- Synergy between μ Opioid Ligands: Evidence for Functional Interactions among μ Opioid Receptor Subtypes (2002) (82)
- Cocaine-induced hyperactivity and sensitization are dependent on GSK3 (2009) (73)
- The determination and application of fixed-dose analgesic combinations for treating multimodal pain. (2010) (73)
- Combination strategies for pain management (2003) (70)
- Drug Combinations: Tests and Analysis with Isoboles (2016) (70)
- Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. (1993) (70)
- Pharmacological evidence that captopril possesses an endothelium-mediated component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. (1991) (69)
- Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity. (1992) (66)
- The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations. (2010) (53)
- The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine. (1978) (52)
- Antinociceptive Synergy, Additivity, and Subadditivity with Combinations of Oral Glucosamine Plus Nonopioid Analgesics in Mice (2003) (52)
- Mechanisms of excision of 5-fluorouracil by uracil DNA glycosylase in normal human cells. (1993) (50)
- Area under a Curve: Trapezoidal and Simpson’s Rules (1987) (49)
- Ketazocines and morphine: effects on gastrointestinal transit after central and peripheral administration. (1983) (49)
- An evaluation of tamoxifen as a partial agonist by classical receptor theory--an explanation of the dual action of tamoxifen. (1984) (49)
- Combinations of Cocaine with Other Dopamine Uptake Inhibitors: Assessment of Additivity (2009) (49)
- Levamisole and cocaine synergism: A prevalent adulterant enhances cocaine's action in vivo (2014) (48)
- Response to Comments on “Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles” (2006) (46)
- Effects of a Cannabinoid1 Receptor Antagonist and Serotonin2C Receptor Agonist Alone and in Combination on Motivation for Palatable Food: A Dose-Addition Analysis Study in Mice (2008) (45)
- Resveratrol in combination with other dietary polyphenols concomitantly enhances antiproliferation and UGT1A1 induction in Caco-2 cells. (2011) (45)
- Synergistic antihypersensitive effects of pregabalin and tapentadol in a rat model of neuropathic pain. (2011) (43)
- Mephedrone (“bath salt”) pharmacology: insights from invertebrates (2012) (43)
- N-Methyl-d-aspartate Antagonists and WIN 55212-2 [4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1-i,j]quinolin-6-one], a Cannabinoid Agonist, Interact to Produce Synergistic Hypothermia (2002) (42)
- Interaction between muscarinic receptor subtype signal transduction pathways mediating bladder contraction. (2002) (41)
- Principles in General Pharmacology (1988) (40)
- Duncan Multiple Range Test (1987) (38)
- Tramadol and several anticonvulsants synergize in attenuating nerve injury-induced allodynia (2008) (38)
- Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine (1997) (38)
- The beta‐lactam antibiotic, ceftriaxone, attenuates morphine‐evoked hyperthermia in rats (2007) (38)
- Gabapentin and the Neurokinin1 Receptor Antagonist CI-1021 Act Synergistically in Two Rat Models of Neuropathic Pain (2002) (37)
- Postulated thermoregulatory roles for different opiate receptors in rats. (1982) (37)
- Statistical analysis of drug combinations for synergism (1993) (36)
- Action potentials in the sensory vagus at the time of coronary infarction. (1967) (35)
- Estimation of the affinity of naloxone at supraspinal and spinal opioid receptors in vivo: studies with receptor selective agonists. (1986) (35)
- Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: An isobolographic analysis (2007) (34)
- Left ventricular wall acceleration and the law of Laplace. (1970) (34)
- Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice (2015) (32)
- Interaction Between Medullary and Spinal δ1 and δ2 Opioid Receptors in the Production of Antinociception in the Rat (1999) (31)
- Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor. (1990) (31)
- The Dose—Response Relation (1979) (31)
- Dunnett’s Test (Comparison with a Control) (1987) (30)
- Midazolam enhances the analgesic properties of dexmedetomidine in the rat. (2010) (30)
- Possible mechanism of hypothermia induced by intracerebroventricular injection of orphanin FQ/nociceptin (2001) (29)
- A scale for assessing the severity of diseases and adverse drug reactions; Application to drug benefit and risk (1979) (29)
- Continuous Multimechanistic Postoperative Analgesia: A Rationale for Transitioning from Intravenous Acetaminophen and Opioids to Oral Formulations (2012) (29)
- Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice (2010) (29)
- Oxycodone combinations for pain relief. (2010) (28)
- Tolerance and cross‐tolerance studies with morphine and ethylketocyclazocine (1982) (28)
- Unexpected and pronounced antinociceptive synergy between spinal acetaminophen (paracetamol) and phentolamine. (2001) (28)
- Effects on the visual system might contribute to some of the cognitive deficits of cancer chemotherapy‐induced ‘chemo‐fog’ (2010) (28)
- The effect of preload on the dissociation constant of norepinephrine in isolated strips of rabbit thoracic aorta. (1974) (27)
- A Novel Role of Cannabinoids: Implication in the Fever Induced by Bacterial Lipopolysaccharide (2007) (27)
- Graded dose—response (1987) (27)
- Ethanol and cocaine: environmental place conditioning, stereotypy, and synergism in planarians. (2014) (26)
- Combination analysis. (2010) (25)
- Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat (1997) (24)
- The dynamic relationship between mu and kappa opioid receptors in body temperature regulation. (2005) (24)
- New mechanism of action of the cancer chemotherapeutic agent 5-fluorouracil in human cells. (1994) (24)
- Kinetics of Drug—Receptor Interaction: Interpreting Dose—Response Data (1979) (23)
- Fixed-dose combinations for emerging treatment of pain (2012) (23)
- Levamisole enhances the rewarding and locomotor-activating effects of cocaine in rats. (2015) (23)
- Self-administration of cocaine–remifentanil mixtures by monkeys: an isobolographic analysis (2008) (22)
- Mann-Whitney Test (2020) (22)
- Morphine-induced mydriasis and fluctuation in the rat: time and dose relationships. (1979) (22)
- Synergistic antidepressant-like effects between a kappa opioid antagonist (LY2444296) and a delta opioid agonist (ADL5859) in the mouse forced swim test. (2016) (22)
- Pharmacologic methods for identification of receptors. (1988) (21)
- l-NAME (Nω-Nitro-l-Arginine Methyl Ester), a Nitric-Oxide Synthase Inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij]quinolin-6-one], a Cannabinoid Agonist, Interact to Evoke Synergistic Hypothermia (2004) (21)
- Use of a programmable protocol timer and data logger in the monitoring of animal behavior (1981) (21)
- A further comment on testing for drug synergism (1992) (21)
- Spinal-Supraspinal and Intrinsic µ-Opioid Receptor Agonist-Norepinephrine Reuptake Inhibitor (MOR-NRI) Synergy of Tapentadol in Diabetic Heat Hyperalgesia in Mice (2013) (21)
- GABAA receptors modulate cannabinoid-evoked hypothermia (2004) (20)
- Characteristics of Photorelaxation in Vascular Smooth Muscle: Evidence Supporting the Hypothesis of Drug-Receptor Equilibrium Disturbance (1975) (20)
- The affinity of morphine for its pharmacologic receptor in vivo. (1982) (20)
- Quantitation of the Contractile Response Mediated by Two Receptors: M2 and M3 Muscarinic Receptor-Mediated Contractions of Human Gastroesophageal Smooth Muscle (2009) (19)
- Characterization of the unusual antinociceptive profile of tramadol in mice (1993) (19)
- Relative Potency I (1987) (19)
- A quantitative study of dopamine control in the rat striatum. (1994) (18)
- Rapid extraction and measurement of morphine and opiate antagonists from rat brain using high-performance liquid chromatography and electrochemical detection. (1982) (18)
- Lack of synergistic interaction between the two mechanisms of action of tapentadol in gastrointestinal transit (2014) (17)
- Receptor discrimination and control of agonist-antagonist binding. (1995) (17)
- Litchfield and Wilcoxon I: Confidence Limits of ED50 (1987) (17)
- Combining Opioid and Adrenergic Mechanisms for Chronic Pain (2014) (17)
- A quantitative study to assess synergistic interactions between urotensin II and angiotensin II. (2008) (16)
- Self-administration of drug mixtures by monkeys: combining drugs with comparable mechanisms of action (2008) (16)
- Subadditive withdrawal from cocaine/κ-opioid agonist combinations in Planaria (2006) (15)
- Chemo fog : cancer chemotherapy-related cognitive impairment (2010) (15)
- pA 2 Analysis I: Schild Plot (1987) (14)
- The relationship between vessel wall tension and the magnitude and frequency of oscillation in rat aorta. (1994) (14)
- Changes in Aorta Alpha1-Adrenoceptor Number and Affinity during One Year of Streptozotocin-Induced Diabetes in Rats (2005) (14)
- Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats (2013) (13)
- Estimation in vivo of the receptor constants of morphine in naive and morphine-tolerant rats. (1982) (13)
- Pocket Book of Integrals and Mathematical Formulas (1991) (13)
- Agmatine and a cannabinoid agonist, WIN 55212-2, interact to produce a hypothermic synergy. (2006) (13)
- Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians. (2007) (13)
- Parallel Lines I: Test for Parallelism (1987) (12)
- On the criteria for classifying opiate agonists in rats (1982) (12)
- Measurement of thermodynamic parameters for norepinephrine contraction of isolated rabbit thoracic aorta. (1985) (12)
- Exponential Growth and Decay (1987) (12)
- Morphine concentrations in the rat after intraperitoneal or subcutaneous injection. (1980) (12)
- Relaxation methods for the determination of drug receptor affinities. (1970) (12)
- Morphine-receptor dissociation constant and the stimulus-effect relation for inhibition of gastrointestinal transit in the rat. (1982) (12)
- A comparison of the receptor constants of morphine and ethylketocyclazocine for analgesia and inhibition of gastrointestinal transit in the rat. (1982) (12)
- Opioid‐sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptors (2019) (11)
- Combinations Of Chemicals (2000) (11)
- Control and oscillation in ligand receptor interactions according to the law of mass action. (1990) (11)
- On deriving the dose-effect relation of an unknown second component: an example using buprenorphine preclinical data. (2010) (11)
- Antivasoconstrictor and Antiaggregatory Activities of Picotamide Unrelated to Thromboxane A2 Antagonism (1997) (11)
- Comparison of human and porcine gastric clasp and sling fiber contraction by M2 and M3 muscarinic receptors. (2010) (11)
- On stability and control of ligand‐receptor interactions according to the mass action law: A theoretical model of chaos (1990) (11)
- The Use of Occupation Isoboles for Analysis of a Response Mediated by Two Receptors: M2 and M3 Muscarinic Receptor Subtype-Induced Mouse Stomach Contractions (2008) (10)
- Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonists. (1996) (10)
- Interaction between medullary and spinal delta1 and delta2 opioid receptors in the production of antinociception in the rat. (1999) (10)
- Perturbation of drug receptor equilibrium in the presence of competitive blocking agents. (1976) (10)
- Miosis and fluctuation in the rabbit pupil: effects of morphine and naloxone. (1977) (10)
- The concept of a changing receptor concentration: implications for the theory of drug action. (1985) (10)
- Henderson—Hasselbalch Equation (1987) (9)
- Pupillographic analysis of morphine action in the rabbit: role to the autonomic nervous system. (1982) (9)
- Construction of Dose—Response Curves: Statistical Considerations (1979) (9)
- Ultraviolet light‐induced photorelaxation of agonist‐contracted rabbit aorta: Further characterization and the estimation of drug‐receptor rate constants (1985) (9)
- Dose-Response Analysis (2000) (9)
- Estimation of the dissociation constant of naloxone in the naive and morphine-tolerant guinea-pig isolated ileum: analysis by the constrained Schild plot. (1982) (9)
- Analysis of the Regression Line (1987) (9)
- Quantal Dose-Response Data: Probit and Logit Analysis (2000) (8)
- Theoretical pharmacology: the quantitative identification of receptors (1981) (8)
- Pronounced hypothermic synergy between systemic baclofen and NOS inhibitor. (2004) (8)
- Receptor theories and quantitative effect versus dose-concentration relationship. (1984) (8)
- Ratio of Means (1987) (8)
- Analysis of Variance I: One-Way (1987) (8)
- Least Significant Difference Test (1987) (8)
- The use of drug-receptor affinity measures in the differentiation of receptors. (1982) (7)
- On the analysis of straight line data in pharmacology and biochemistry. (1981) (7)
- t -Test I: Grouped Data (1987) (7)
- Cocaine synergism with α agonists in rat aorta: computational analysis reveals an action beyond reuptake inhibition. (2013) (7)
- Determination of the stimulus-response relation for three alpha-adrenergic agonists on rabbit aorta. (1979) (7)
- The Analgesic Interaction of Misoprostol with Nonsteroidal Anti-Inflammatory Drugs. (1996) (7)
- Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the rat. (1981) (7)
- Schild (apparent pA 2) analysis of a ?-opioid antagonist in Planaria (2006) (6)
- Linear Regression I (1987) (6)
- Receptor regulation, competitive antagonism and pA2. (1992) (6)
- Enzyme Kinetics I: Michaelis—Menten Equation (1987) (6)
- Purification and properties of the uracil DNA glycosylase from Bloom's syndrome. (1991) (6)
- Morphine potentiates dextromethorphan-induced vasodilation in rat superior mesenteric artery. (2004) (6)
- Effects of drug combinations on smooth muscle cell proliferation: an isobolographic analysis. (2006) (6)
- 428 – ISTUDIES ON THE QUANTITATIVE ANTAGONISM OF μ AND K RECEPTOR AGONISTS BY NALOXONE USING THE RAT TAIL COMPRESSION TEST (1978) (6)
- Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. (2006) (6)
- Kinetics of release of iron from reticuloendothelial system. (1968) (5)
- Further characterization of a control model for ligand-receptor interaction: Phase plane geometry, stability, and oscillation (2006) (5)
- Dose-response Analysis: A Further Discussion (2000) (5)
- Chemo fog: cancer chemotherapy-related cognitive impairment. Preface. (2010) (5)
- Academic‐Industrial Cooperative Graduate Program in Clinical Pharmacology (1988) (5)
- Systems, Controls, Embedded Systems, Energy, and Machines (2016) (5)
- COMBINATIONS OF DRUGS THAT PRODUCE OPPOSITE EFFECTS (2011) (5)
- Baclofen and NOS inhibitors interact to evoke synergistic hypothermia in rats. (2006) (5)
- Calculations for Combination Drug Analysis (2000) (5)
- Different Experimental Designs (2000) (5)
- Computer-assisted instruction in pharmacokinetics for second-year students. (1988) (4)
- Analysis of Variance II: Two-Way, Single Observation (1987) (4)
- Quantal Dose—Response: Probits (1981) (4)
- Differentiation of apomorphine from bromocriptine, piribidel and TRH by chronic administration in rats (2004) (4)
- Further studies on the action of ultraviolet light on vascular smooth muscle: effect of partial irreversible receptor blockade. (1977) (4)
- Mathematics courses for physicians and other life scientists. (1969) (4)
- Capsaicin and nitric oxide synthase inhibitor interact to evoke a hypothermic synergy (2006) (4)
- Chaos and control in mass-action binding of endogenous compounds (1994) (4)
- First-Order Drug Decay (1987) (4)
- Nmda antagonists and win 55212 2, a cannabinoid agonist, interact to produce synergistic hypothermia (2002) (3)
- Control and stability of ligand receptor interaction in the presence of a competitive compound. (1991) (3)
- Schild (apparent pA2) analysis of a kappa-opioid antagonist in Planaria. (2006) (3)
- Extraction and measurement of morphine: correlation of brain level and s.c. dose in drug-naive and morphine-tolerant rats. (1982) (3)
- Use of a μ-antisense oligodeoxynucleotide as a μ opioid receptor noncompetitive antagonist in vivo (1996) (3)
- Ethylketocyclazocine and morphine: A comparison of their efficacies on gastrointestinal transit (GIT) after central and peripheral administration to rats (1981) (3)
- Commentary on Neostigmine Interactions with Non steroidal Anti‐inflammatory Drugs by Miranda et al. (2002) (3)
- A Program for Analyzing Synergistic Interactions from Dose-Effect Data (1998) (3)
- Effects of a CB1 receptor antagonist and 5‐HT2C receptor agonist alone and in combination on motivation for palatable food: a dose‐addition analysis study in mice (2008) (3)
- On the quantitation of an agonist with dual but opposing components of action: application to vascular endothelial relaxation. (2011) (3)
- Effects of ultraviolet radiation and angiotensin on calcium binding in rabbit aortic microsomes. (1980) (3)
- The effect of lowered extracellular Na+ concentration on ultraviolet light-induced relaxation of vasoconstricted rabbit isolated thoracic aorta. (1992) (3)
- Interrelations of cardiac necrosis, acute hypotension, and ventricular fibrillation. (1968) (3)
- Theoretical basis for the determination of the molecularity of drug-receptor reactions and affinity of agonists. (1968) (3)
- Pharmacokinetics IV: Absorptive Route of Administration Plasma Concentration-Time Data (1987) (3)
- Altered vascular responsiveness to norepinephrine following withdrawal of verapamil in rabbits. (1985) (3)
- pA 2 Analysis III: Constrained Plot (1987) (3)
- Use of a mu-antisense oligodeoxynucleotide as a mu opioid receptor noncompetitive antagonist in vivo. (1996) (3)
- Computers, Software Engineering, and Digital Devices (2005) (2)
- The association of age and current world cancer mortality rates in relation to a century of cancer deaths in the U.S. (1993) (2)
- Isolated Preparations: Dose—Response Data (1979) (2)
- Evidence for the role of conditioning in the development of tolerance to morphine-induced inhibition of gastrointestinal motility in rats (1982) (2)
- Drug Binding and Drug Effect (1979) (2)
- The Composite Additive Curve (2000) (2)
- t-Test II: Paired Data (1987) (2)
- Comparison of human and porcine gastric clasp and sling fiber contraction by M 2 and M 3 muscarinic receptors (2010) (2)
- Response Surface Analysis of Drug Combinations (2000) (2)
- The effect of preload on the dissociation constant of phentolamine in isolated rabbit thoracic aorta. (1981) (2)
- Determination of the functional dissociation constant of a partial agonist by comparison with a higher efficacy agonist. (1991) (2)
- Dissociation Constant III: Perturbation Methods (Rate Constants in the Drug-Receptor Reaction) (1987) (2)
- Searching for Synergism Among Combinations of Drugs of Abuse and the Use of Isobolographic Analysis (2012) (1)
- Ornade® (Smith Kline & French) (1982) (1)
- Chemotherapy-Induced Neuropathic Pain (2012) (1)
- Effects of chronic treatment with verapamil on adrenoceptor-mediated contraction of rabbit aorta. (1989) (1)
- ‘Null Method’ Determination of Drug Biophase Concentration (2012) (1)
- Determination of the drug-receptor dissociation constant of endothelin-1 using photorelaxation of rabbit isolated thoracic aorta. (1993) (1)
- A search for interaction among combinations of drugs of abuse and the use of isobolographic analysis (2013) (1)
- Estimation of half life of ICV administered naloxone in rats using the time-dependent form of the equation for competitive antagonism (1981) (1)
- Additive and superadditive vasodilating combinations of diltiazem and glyceryl trinitrate in isolated rabbit aorta (1992) (1)
- Linear Regression: A Further Discussion (2000) (1)
- Gyro results (1990) (1)
- Relative Potency II: Statistical Analysis (Graded Data) (1987) (1)
- Modulation of Morphine Analgesia, Antinociceptive Tolerance, and Mu-Opioid Receptor Binding by the Cannabinoid CB2 Receptor Agonist O-1966 (2022) (1)
- Tylenol®/Codeine (McNeil) (1982) (1)
- Litchfield and Wilcoxon II (1987) (1)
- Current and historical mortality from cancer and cardiovascular disease in relation to age: U.S. and world values. (1995) (1)
- Modified 'Joyce model' of opioid dependence/withdrawal. (2006) (1)
- Donnatal® (Robins): Phenobarbital: Hyoscyamine sulfate: Atropine sulfate: Hyoscine hydrobromide (1982) (1)
- Arterial denervation and cyclosporine therapy diminish endothelium-dependent relaxation (1990) (1)
- Estimation of steroids in rabbit aorta by high performance liquid chromatography (1989) (1)
- Dosage and Cosncentration: Drug Stock Solutions (1987) (0)
- Phenaphen® /Codeine (Robins) (1982) (0)
- Flexeril® (Merck Sharp & Dohme) (1982) (0)
- Ovulen 21® (Searle) (1982) (0)
- Pharmacodynamics: The Interaction of Drugs with Receptors (1988) (0)
- Proportions: Confidence Limits (1987) (0)
- ‘Null Method’ Determination of Drug Biophase Concentration (2011) (0)
- Using dose‐equivalence theory to quantify endothelial function (2011) (0)
- Apresoline® (Ciba): Hydralazine HCl (1982) (0)
- Stelazine® (Smith Kline & French) (1982) (0)
- Butisol® Sodium (McNeil) (1982) (0)
- Morphine receptor dissociation constant (K(A)) and morphine efficacy determined by the charcoal meal test in rats (1981) (0)
- T1238 Comparison of Muscarinic Receptor Subtypes Mediating Contraction of Human and Pig Gastric Clasp and Sling Fibers (2009) (0)
- Synthroid® (Flint): Levothyroxine sodium (1982) (0)
- Analysis Of A Single Dose Combination (2000) (0)
- Methylphenidate and impulsivity: a comparison of effects of methylphenidate enantiomers on delay discounting in rats (2013) (0)
- Tri-Vi-Flor® Drops (Mead Johnson) (1982) (0)
- Dose related morphine mydriasis in the rat (1977) (0)
- pA2 Analysis II: Time-Dependent Method (1987) (0)
- Slow-K® (Ciba) (1982) (0)
- Ilosone® (Dista): Erythromycin estolate (1982) (0)
- Introduction to Specific Drug Action and Membrane Surface Phenomena (1988) (0)
- General Principles: History and Overview (1988) (0)
- Gyne—Lotrimin® (Schering) (1982) (0)
- Antivert® (Roerig): Meclizine HCl (1982) (0)
- Septra® DS (Burroughs Wellcome) (1982) (0)
- Sorbitrate® (Stuart): Isosorbide dinitrate (1982) (0)
- Macrodantin® (Norwich-Eaton) (1982) (0)
- Analysis of Drug Combinations Over a Range of Drug Ratios (2000) (0)
- Pharmacokinetics V: Renal Clearance (1987) (0)
- Related articles (2012) (0)
- Motrin® (Upjohn): Ibuprofen (1982) (0)
- Vasodilan® (Mead Johnson Pharm.) (1982) (0)
- Medrol® Oral (Upjohn) (1982) (0)
- Equagesic® (Wyeth): Meprobamate: Ethoheptazine citrate: Aspirin (1982) (0)
- Current and historical mortality from cancer and cardiovascular disease in relation to age: U.S. and world values (1995) (0)
- Ser-Ap-Es® (Ciba) (1982) (0)
- Nitro-Bid® (Marion) (1982) (0)
- Chlor-Trimeton® (Schering) (1982) (0)
- Linear Regression II: Lines through Origin (1987) (0)
- Theo-Dur® (Key) (1982) (0)
- Lasix® (Hoechst-Roussel) (1982) (0)
- Drugs and Receptors: Chemical Bonding (1988) (0)
- Valisone® (Schering): Betamethasone valerate (1982) (0)
- Meclomen® (Parke-Davis) (1982) (0)
- Pavabid® (Marion): Papaverine HCl (1982) (0)
- Pharmacokinetics III: Volume of Distribution (1987) (0)
- and Therapeutics (2008) (0)
- Choledyl® (Parke-Davis) (1982) (0)
- Lanoxin® (Burroughs Wellcome) (1982) (0)
- Pyridium® (Parke-Davis) (1982) (0)
- The widespread use of the geometric mean. (1988) (0)
- Kenalog® Dermatologic (Squibb) (1982) (0)
- Provera® (Upjohn): Medroxyprogesterone acetate (1982) (0)
- Fastin® (Beecham): Phentermine HCl (1982) (0)
- V-Cillin K® (Lilly) (1982) (0)
- Indocin® (Merck Sharp & Dohme) (1982) (0)
- Thorazine® (Smith Kline & French) (1982) (0)
- Lotrimin® (Schering): Clotrimazole (1982) (0)
- Benylin® Cough Syrup (Parke-Davis) (1982) (0)
- Phenergan® VC Expectorant/Codeine (Wyeth) (1982) (0)
- Minocin® (Lederle): Minocycline HCl (1982) (0)
- Tuss—Ornade® (Smith Kline & French) (1982) (0)
- Hydrodiuril® (Merck Sharp & Dohme) (1982) (0)
- Diuril® (Merck Sharp & Dohme) (1982) (0)
- Empirin/Codeine (Burroughs Wellcome) (1982) (0)
- Synalgos-DC® (Ives) (1982) (0)
- Enzyme Kinetics II: Competitive Inhibition (1987) (0)
- Brethine® (Geigy): Terbutaline sulfate (1982) (0)
- Librium® (Roche): Chlordiazepoxide HCl (1982) (0)
- Elementary Algebra and Geometry (1999) (0)
- Tagamet® (Smith Kline & French) (1982) (0)
- Aldoril® (Merck Sharp & Dohme) (1982) (0)
- Enzyme Kinetics III: Noncompetitive Inhibition (1987) (0)
- Lo/Ovral® 28 (Wyeth) (1982) (0)
- Erythrocin® (Abbott): Erythromycin stearate and lactobionate (1982) (0)
- Actifed® (Burroughs Wellcome) (1982) (0)
- Achromycin®-V (Lederle) (1982) (0)
- Response Surface Analysis of Synergism Between Morphine and Clonidine 1 (1999) (0)
- Tussionex® (Pennwalt): Hydrocodone resin complex: Phenyltoloxamine resin complex (1982) (0)
- Analysis of Variance III: Two-Way, with Replication (1987) (0)
- Monistat® 7 (Ortho Pharm.) (1982) (0)
- Aldomet® (Merck Sharp & Dohme) (1982) (0)
- Enduron® (Abbott): Methyclothiazide (1982) (0)
- Percodan® (Endo): Oxycodone HCl: Oxycodone terephthalate: Aspirin (1982) (0)
- Dissociation Constant II: Partial Agonists (1987) (0)
- Comparison of Human and Porcine Gastric Clasp and Sling Fiber (2010) (0)
- Table of Integrals: Indefinite and Definite Integrals (2015) (0)
- Mellaril® (Sandoz): Thioridazine HCl (1982) (0)
- Triavil® (Merck Sharp & Dohme) (1982) (0)
- Librax® (Roche): Chlordiazepoxide HCl: Clidinium bromide (1982) (0)
- Dilantin® Sodium (Parke-Davis) (1982) (0)
- Orinase® (Upjohn): Tolbutamide (1982) (0)
- Statistical Concepts and Tests of Hypotheses (2000) (0)
- Basic Review Statistical analysis of drug combinations for synergism (2002) (0)
- Combid® (Smith Kline & French) (1982) (0)
- Disruption of Drug Effects (Dopamine, Nicotine, Pilocarpine, κ-Opioid) in Planarians by UV Light (2012) (0)
- Experimental Design and Analysis of Drug Combinations Applicable to Chemotherapy-Induced Neuropathic Pain (2012) (0)
- Determinants, Matrices, and Linear Systems of Equations (2018) (0)
- Ceclor® (Lilly): Cefaclor (1982) (0)
- Functions and Relations (1979) (0)
- Kwell® (Reed & Carnick) (1982) (0)
- Bendectin® (Merrell-Dow) (1982) (0)
- Table of Derivatives (2018) (0)
- Neosporin® Ophthalmic (Burroughs Wellcome) (1982) (0)
- Norpace (Searle): Disopyramide phosphate (1982) (0)
- Tigan® (Beecham): Trimethobenzamide HCl (1982) (0)
- Quibron® (Mead Johnson) (1982) (0)
- Phenergan® VC Expectorant (Wyeth) (1982) (0)
- Sumycin® (Squibb): Tetracycline HCl (1982) (0)
- Vanceril® (Schering): Beclomethasone dipropionate inhaler (1982) (0)
- Sinequan® (Roerig): Doxepin HCl (1982) (0)
- Adolescent drug use: altered dopamine feedback control (2011) (0)
- Pharmacokinetics II: Multiple Intravenous Injections (1987) (0)
- Stuartnatal 1 + 1® Tablets (Stuart) (1982) (0)
- Nitrostat® (Parke-Davis) (1982) (0)
- Premarin® (Ayerst): Conjugated estrogens (1982) (0)
- Pharmacokinetics VII: Multiple Dosing from Absorptive Site (1987) (0)
- Artane® (Lederle): Trihexyphenidyl HCl (1982) (0)
- Haldol® (McNeil): Haloperidol (1982) (0)
- Isordil® (Ives): Isosorbide dinitrate (1982) (0)
- Regroton® (USV): Chlorthalidone: Reserpine (1982) (0)
- Pharmacokinetics I: Constant Infusion with First-Order Elimination (1987) (0)
- Flagyl® (Searle): Metronidazole (1982) (0)
- Future directions. (2010) (0)
- K-Lyte® (Mead Johnson) (1982) (0)
- Imodium® (Ortho): Loperamide HCl (1982) (0)
- E-Mycin® (Upjohn) (1982) (0)
- Pen-Vee-K® (Wyeth) (1982) (0)
- Series, NumberFacts, and Theory (2008) (0)
- Lomotil® (Searle): Diphenoxylate HCl: Atropine sulfate (1982) (0)
- ULTRA-LOW-DOSEANTAGONIST PREVENTS CANNABINOID-INDUCEDTOLERANCE (2005) (0)
- The Rate of Drug-Receptor Interactions (1988) (0)
- L -NAME ( N (cid:1) -Nitro- L -Arginine Methyl Ester), a Nitric-Oxide Synthase Inhibitor, and WIN 55212-2 [4,5-dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6 -pyrrolo[3,2,1 ij a Cannabinoid Agonist, Interact to Evoke Synergistic Hypothermia (2004) (0)
- Periactin® (Merck Sharp & Dohme) (1982) (0)
- Atarax® (Roerig): Hydroxyzine HCl (1982) (0)
- Nonlinear Regression Analysis (2000) (0)
- Hygroton® (USV): Chlorthalidone (1982) (0)
- Aldactone® (Searle): Spironolactone (1982) (0)
- Benadryl Elixir® (Parke-Davis) (1982) (0)
- Clinoril® (Merck Sharp & Dohme) (1982) (0)
- Mean, Standard Deviation, and Confidence Limits (1987) (0)
- Bentyl® (Merrell-National) (1982) (0)
- Slo-Phyllin® Gyrocaps® (Dooner) (1982) (0)
- Isobolographic Method and Invertebrate (Planarian) Model for Evaluating Combinations of Waterways Pollutants (2012) (0)
- Penicillin V Potassium (1982) (0)
- 580 The M2 Muscarinic Receptor Plays a Greater Role in Mediating Contraction of Sling and Clasp Fibers Than Esophageal Smooth Muscle Fibers (2009) (0)
- Actifed-C® Expectorant (Burroughs Wellcome) (1982) (0)
- Book Review:Pharmacology. An Introduction to Drugs. Michael C. Gerald (1982) (0)
- Coumadin® (Endo): Crystalline warfarin sodium (1982) (0)
- Cyclospasmol® (Ives): Cyclandelate (1982) (0)
- Talwin® (Winthrop): Pentazocine HCl (1982) (0)
- Phenergan® Expectorant/Codeine (Wyeth): Promethazine HCl: Guaiacolsulfonate potassium: Sodium citrate: Citric acid anhydrous: Ipecac fluid extract: Alcohol: Codeine phosphate (1982) (0)
- Lo/Ovral® (Wyeth) (1982) (0)
- Poly-Vi-Flor® Chewable (Mead Johnson) (1982) (0)
- Dimetane Expectorant® (Robins) (1982) (0)
- Centrax® (Parke-Davis) (1982) (0)
- Tolectin® DS (McNeil) (1982) (0)
- Elavil® (Merck Sharp & Dohme) (1982) (0)
- Sulamyd® Sodium (Schering) (1982) (0)
- Compazine® (Smith Kline & French) (1982) (0)
- Ovral® 28 (Wyeth) (1982) (0)
- Cortisporin® Otic (Burroughs Wellcome) (1982) (0)
- Dissociation Constant I: Agonists (1987) (0)
- Darvon Compound-65 (Lilly) (1982) (0)
- Series, Number Facts, and Theory (2015) (0)
- Hydropres® (Merck Sharp & Dohme) (1982) (0)
- B111 EVALUATION OF MULTIPLICATIVE OPIOID ANTAGONIST INTERACTIONS IN THE RAT WARM-WATER TAIL-WITHDRAWAL ASSAY (2005) (0)
- ULTRAVIOLET RADIATION-INDUCED NOCICEPTION: BASIS FOR A NOVEL ANALGESIC TEST IN MICE (1980) (0)
- Aldactazide® (Searle): Spironolactone: Hydrochlorothiazide (1982) (0)
- Dimetapp® (Robins): Brompheniramine maleate: Phenylephrine HCl: Phenylpropanolamine HCl (1982) (0)
- Cross-tolerance between morphine (M) and ethyl-ketocyclazocine (EK) using analgesia and gastrointestinal motility as endpoints in rats (1982) (0)
- Lopressor® (Geigy): Metoprolol tartrate (1982) (0)
- Septra® (Burroughs Wellcome) (1982) (0)
- Cogentin® (Merck Sharp & Dohme) (1982) (0)
- Pocket Book of Integrals and Mathematical Formulas, 4th Edition (2008) (0)
- Benadryl® Capsules/Tablets (Parke-Davis) (1982) (0)
- Limbitrol® (Roche): Chlordiazepoxide: Amitriptyline HCl (1982) (0)
- Phenergan® VC Expectorant (Wyeth): Promethazine HCl: Guaiacolsulfonate potassium: Sodium citrate: Citric acid: Ipecac fluid extract: Alcohol: Phenylephrine HCl (1982) (0)
- Ambenyl® Expectorant (Marion) (1982) (0)
- Pharmacokinetics VI: Renal Excretion Data Following Intravenous Administration (1987) (0)
- Zyloprim® (Burroughs Wellcome) (1982) (0)
- Anusol-HC® (Parke-Davis) (1982) (0)
- Elementary Algebraand Geometry (2008) (0)
- Drug Metabolism (Biotransformation) (1988) (0)
- Zomax® (McNeil): Zomepirac sodium (1982) (0)
- Mycolog® (Squibb): Triamcinolone acetonide: Gramicidin: Neomycin sulfate: Nystatin (1982) (0)
- Timoptic® (Merck Sharp & Dohme) (1982) (0)
- Drixoral® (Schering): Dexbrompheniramine maleate: Pseudoephedrine sulfate (1982) (0)
- Parallel Lines II: Construction of Parallel Lines (1987) (0)
- Kinetic studies on binding of [3H] beta-funaltrexamine ([3H] beta-FNA) to mu opioid receptors. (1990) (0)
- Hydergine® (Sandoz): Dihydroergocornine mesylate: Dihydroergocristine mesylate: Dihydroergocryptine mesylate (1982) (0)
- Tenuate® (Merrell-National) (1982) (0)
- Effects of Na/sup +/ on ultraviolet light-induced photorelaxation and c-GMP levels in rabbit aorta (1986) (0)
- Atromid-S® (Ayerst) (1982) (0)
- Tofranil® (Geigy): Imipramine HCl (1982) (0)
- Tolinase® (Upjohn): Tolazamide (1982) (0)
- Dyazide® (Smith Kline & French) (1982) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ronald J. Tallarida?
Ronald J. Tallarida is affiliated with the following schools:
